国药股份：第三季度净利润同比增长13.10%

Core Insights - The company reported a net profit increase of 13.10% year-on-year for the third quarter of 2025 [1] - The total revenue for the third quarter reached 13.747 billion yuan, reflecting a year-on-year growth of 3.58% [1] Financial Performance - The company's revenue for Q3 2025 was 13.747 billion yuan, which is an increase of 3.58% compared to the same period last year [1] - The net profit attributable to shareholders was 544 million yuan, showing a growth of 13.10% year-on-year [1]